NASDAQ
Bio-Techne Corp (TECH)
♥ 346 Thanks from members
Bio-Techne Corp (TECH) net web sentiment reflects strong market consolidation and investor optimism, heavily driven by its definitive $73.00 per share cash buyout agreement with Merck KGaA.
Special Briefing
How to Live for 300 Years: The Longevity Sandbox
Explore plasma cleansing, somatic organ swaps, and BCI.